Literature DB >> 21852011

Survivin inhibition and DNA double-strand break repair: a molecular mechanism to overcome radioresistance in glioblastoma.

Sebastian Reichert1, Claus Rödel, Johanna Mirsch, Patrick N Harter, Maja T Tomicic, Michel Mittelbronn, Bernd Kaina, Franz Rödel.   

Abstract

BACKGROUND AND
PURPOSE: Gliomas display prime examples of ionizing radiation (IR) resistant tumors. The IAP Survivin is reported to be critically involved in radiation resistance by anti-apoptotic and by caspase-independent mechanisms. The present study aimed to elucidate an interrelationship between Survivin's cellular localization and DNA damage repair in glioma cells.
MATERIAL AND METHODS: Cellular distribution and nuclear complex formation were assayed by immunoblotting, immunofluorescence staining and co-immunoprecipitation of Survivin bound proteins in LN229 glioblastoma cells. Apoptosis induction, survival and DNA repair following IR were assayed by means of caspase3/7 activity, clonogenic assay, γ-H2AX/53BP1 foci formation, single cell gel electrophoresis assay, and DNA-PKcs kinase assay in the presence of Survivin siRNA or over expression of Survivin-GFP.
RESULTS: Following irradiation, we observed a nuclear accumulation and a direct interrelationship between Survivin, MDC1, γ-H2AX, 53BP1 and DNA-PKcs, which was confirmed by immunofluorescence co-localization. Survivin downregulation by siRNA resulted in an increased apoptotic fraction, decreased clonogenic survival and increased DNA-damage, as demonstrated by higher amount of DNA breaks and an increased amount of γ-H2AX/53BP1 foci post irradiation. Furthermore, we detected in Survivin-depleted LN229 cells a hampered S2056 (auto)phosphorylation and a significantly decreased DNA-PKcs kinase activity.
CONCLUSION: Nuclear accumulation of Survivin and interaction with components of the DNA-double-strand break (DSB) repair machinery indicates Survivin to regulate DSB damage repair that leads to a significant improvement of survival of LN229 glioblastoma cells. Copyright Â
© 2011 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21852011     DOI: 10.1016/j.radonc.2011.06.037

Source DB:  PubMed          Journal:  Radiother Oncol        ISSN: 0167-8140            Impact factor:   6.280


  34 in total

Review 1.  Pediatric Craniopharyngiomas: A Primer for the Skull Base Surgeon.

Authors:  Christopher Salvatore Graffeo; Avital Perry; Michael J Link; David J Daniels
Journal:  J Neurol Surg B Skull Base       Date:  2018-01-19

2.  Honokiol Radiosensitizes Squamous Cell Carcinoma of the Head and Neck by Downregulation of Survivin.

Authors:  Xu Wang; Jonathan J Beitler; Wen Huang; Guo Chen; Guoqing Qian; Kelly Magliocca; Mihir R Patel; Amy Y Chen; Jun Zhang; Sreenivas Nannapaneni; Sungjin Kim; Zhengjia Chen; Xingming Deng; Nabil F Saba; Zhuo Georgia Chen; Jack L Arbiser; Dong M Shin
Journal:  Clin Cancer Res       Date:  2017-11-27       Impact factor: 12.531

3.  Survivin, a target to modulate the radiosensitivity of Ewing's sarcoma.

Authors:  B Greve; F Sheikh-Mounessi; B Kemper; I Ernst; M Götte; H T Eich
Journal:  Strahlenther Onkol       Date:  2012-10-10       Impact factor: 3.621

4.  Tetra-O-methyl nordihydroguaiaretic acid, an inhibitor of Sp1-mediated survivin transcription, induces apoptosis and acts synergistically with chemo-radiotherapy in glioblastoma cells.

Authors:  Angel Mauricio Castro-Gamero; Kleiton Silva Borges; Daniel Antunes Moreno; Veridiana Kill Suazo; Mayara Missono Fujinami; Rosane de Paula Gomes Queiroz; Harley Francisco de Oliveira; Carlos Gilberto Carlotti; Carlos Alberto Scrideli; Luiz Gonzaga Tone
Journal:  Invest New Drugs       Date:  2013-01-09       Impact factor: 3.850

Review 5.  The DNA Double-Strand Break Repair in Glioma: Molecular Players and Therapeutic Strategies.

Authors:  Semer Maksoud
Journal:  Mol Neurobiol       Date:  2022-06-13       Impact factor: 5.682

6.  Chk2 phosphorylation of survivin-DeltaEx3 contributes to a DNA damage-sensing checkpoint in cancer.

Authors:  Alessia Lopergolo; Michele Tavecchio; Sofia Lisanti; Jagadish C Ghosh; Takehiko Dohi; Alice Faversani; Valentina Vaira; Silvano Bosari; Nobuhiko Tanigawa; Domenico Delia; Andrew V Kossenkov; Louise C Showe; Dario C Altieri
Journal:  Cancer Res       Date:  2012-05-14       Impact factor: 12.701

7.  Anti-angiogenic therapy increases intratumoral adenovirus distribution by inducing collagen degradation.

Authors:  B Thaci; I V Ulasov; A U Ahmed; S D Ferguson; Y Han; M S Lesniak
Journal:  Gene Ther       Date:  2012-06-07       Impact factor: 5.250

8.  Weight loss normalizes enhanced expression of the oncogene survivin in visceral adipose tissue and blood leukocytes from individuals with obesity.

Authors:  Andrea G Izquierdo; Marcos C Carreira; Gemma Rodriguez-Carnero; Alfredo Fernandez-Quintela; Aurelio M Sueiro; Miguel A Martinez-Olmos; German Guzman; Daniel De Luis; Marcela A S Pinhel; Carolina F Nicoletti; Carla B Nonino; Francisco J Ortega; Maria P Portillo; Jose M Fernandez-Real; Felipe F Casanueva; Ana B Crujeiras
Journal:  Int J Obes (Lond)       Date:  2020-06-16       Impact factor: 5.095

9.  Serum Survivin Levels and Outcome of Chemotherapy in Patients with Malignant Mesothelioma.

Authors:  Katja Goričar; Viljem Kovač; Alenka Franko; Metoda Dodič-Fikfak; Vita Dolžan
Journal:  Dis Markers       Date:  2015-09-16       Impact factor: 3.434

10.  The SMAC mimetic BV6 sensitizes colorectal cancer cells to ionizing radiation by interfering with DNA repair processes and enhancing apoptosis.

Authors:  Stephanie Hehlgans; Julius Oppermann; Sebastian Reichert; Simone Fulda; Claus Rödel; Franz Rödel
Journal:  Radiat Oncol       Date:  2015-09-17       Impact factor: 3.481

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.